Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer
Articles > Article · 2018
Authors: Haci Ahmet Bircan, Nilgun Gurbuz, Apar Pataer, Ayşe CANER, Nermin Kahraman, Emine Bayraktar, Recep Bayraktar, Mumin Alper Erdogan, Nashwa Kabil, Bulent Ozpolat
LUNG CANCER, Journal Indexed in SCI Expanded, International, 2018, vol 124, pp 31-39
DOI: 10.1016/j.lungcan.2018.07.027
Summary
Objectives: Lung cancer is the leading cause of cancer related deaths in worldwide. Despite recent advances in treatment options, patient survival has not improved substantially due to lack of commonly expressed molecular targets and effective targeted therapeutics. Thus, better understanding of the biology of lung cancer and identification of novel therapeutic targets are urgently needed for development of highly effective molecularly targeted therapies.